Highlights Insulet Corporation

Equities

PODD

US45784P1012

Real-time Estimate Cboe BZX Other stock markets 01:31:00 10/05/2024 am IST			5-day change	1st Jan Change
176.6 ^USD	+0.58%		+2.47%	-18.10%

12:30pm	China trade heats up, UK rates in view	RE
07/05	Wolfe Upgrades Insulet to Outperform From Peerperform With $200 Price Target	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

US Equity Markets Close Higher Wednesday as Fed Holds Rates Steady	21/03	MT
3M Board Approves Healthcare Unit Spinoff -- Update	09/03	DJ
Insulet Corporation Presents Positive Results from its First Randomized Controlled Trial Showing Improved Glycemic and Patient-Reported Outcomes in Type 1 Diabetes with the Omnipod 5 Automated Insulin Delivery System (Omnipod 5)	08/03	CI
Insulet Corporation to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17Th International Conference on Advanced Technologies & Treatments for Diabetes	05/03	CI
Stocks in motion: Alphabet drops as Microsoft signs another AI partnership	26/02
Insulet forecasts weak annual revenue growth; shares drop	23/02	RE
Insulet Q4 Adjusted Earnings, Revenue Increase; Q1, 2024 Revenue Outlook Set	23/02	MT
Earnings Flash (PODD) INSULET CORPORATION Posts Q4 EPS $1.40, vs. Street Est of $0.66	23/02	MT
Earnings Flash (PODD) INSULET CORPORATION Reports Q4 Revenue $509.8M, vs. Street Est of $461.1M	23/02	MT
Insulet Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	23/02	CI
Insulet beats quarterly profit estimates on strong demand for insulin pumps	23/02	RE
Insulet Corporation Provides Unaudited Revenue Guidance for the Quarter Ending March 31, 2024 and Full Year Ending December 31, 2024	23/02	CI
Insulet's Omnipod 5 Receives CE Mark for Abbott FreeStyle Libre 2 Plus Integration	07/02	MT
Insulet Q3 Adjusted Net Income, Revenue Rise; 2023 Revenue Growth Guidance Boosted; Shares Jump After Hours	03/11	MT
Insulet lifts sales growth forecast on resilient demand for insulin pumps	03/11	RE
Earnings Flash (PODD) INSULET CORPORATION Reports Q3 Revenue $432.7M, vs. Street Est of $414.2M	03/11	MT
Earnings Flash (PODD) INSULET CORPORATION Reports Q3 EPS $0.71, vs. Street Est of $0.41	03/11	MT
Insulet Corporation Provides Revenue Guidance for the Fourth Quarter and Year Ending December 31, 2023	03/11	CI
Insulet Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	03/11	CI
Insulet Says US FDA Clears its Omnipod 5 App for iPhone	23/23/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Insulet Corporation

Equities

PODD

US45784P1012

Highlights

Filters